Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Home News ArchiveNeuroSense files U.S. patent application for traumatic brain injury

Live News EQUITY FLASH L impact Oct 19, 2026, 12:25 PM UTC

NeuroSense files U.S. patent application for traumatic brain injury

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

NRSNW

Related stories

TCGX Acquisition to Merge With TriGemX in $361 Million SPAC Deal TCGX Acquisition signed a business combination agreement valuing TriGemX at a $361 million pre-money equity value. The deal includes a $160 million PIPE and targets a Q1 2027 close M impact | EQUITY | Oct 19, 2026, 01:23 PM UTC SkyAI Launches $3 Cash Tender Offer for Up to 67.1 Million Shares and Warrants SkyAI commenced a cash tender offer to buy up to 95% of each class of its outstanding common stock and warrants at $3.00 per share or warrant. M impact | EQUITY | Oct 19, 2026, 01:23 PM UTC Goldman Sachs Upgrades CoreWeave to Buy as Shares Jump 6% Goldman Sachs upgraded CoreWeave from Neutral to Buy, and its shares rose 6% in premarket trading Monday. CoreWeave debt issued in June at a 9.675% yield traded near 15% last week. M impact | EQUITY | Oct 19, 2026, 01:21 PM UTC Cleveland-Cliffs Raises 2027 Outlook, Posts First Quarterly Profit in Over Two Years The steelmaker raised its 2027 core profit forecast after stronger prices and lower costs helped it post its first quarterly profit in more than two years. Shares rose as much as 1 M impact | EQUITY | Oct 19, 2026, 01:20 PM UTC Veradermics Says Oral Hair-Loss Drug Boosted Growth in Late-Stage Study Veradermics said its oral pill helped increase hair growth in men with pattern hair loss in a late-stage study. Shares rose 7.5% to $117 in premarket trading. M impact | EQUITY | Oct 19, 2026, 01:19 PM UTC Euroseas Agrees to Sell M/V Evridiki G for About $26 Million M impact | EQUITY | Oct 19, 2026, 01:18 PM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Market Context
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.